Author: Alan Condon

Zolgensma, a gene therapy drug for spinal muscular atrophy, has been on the market since June 2019 and is widely reported to be the most expensive drug in the world.

Medical cannabis operator Curaleaf appointed Jaswinder Grover, MD, Feb. 3 to its board of directors.

Neurosurgeon Ali Raja, MD, on Feb. 3 joined Arkansas Surgical Hospital in Little Rock.

7D Surgical on Feb. 3 unveiled several expansions to its spine and cranial product lines.

A machine-learning algorithm recognized predictive factors linked with worse outcomes for patients undergoing arthroscopic surgery to treat femoroacetabular impingement of the hip.

Steven Cyr, MD, is now providing stem cell treatments at SASpine in San Antonio.

Louisville, Ky.-based UofL successfully performed its 1,000th joint replacement with Stryker's Mako robotic system in January, according to The Louisville Cardinal.

Founded in 1970, by Richard Rothman, MD, PhD, Rothman Orthopaedic Institute has grown from a single office in Philadelphia to almost 40 office locations across Pennsylvania, New Jersey and New York and is renowned for its treatment of musculoskeletal issues.

McGinley Orthopedics on Jan. 31 launched its Lever Action Plate System.

Alexander Ropper, MD, is assistant professor and director of spinal neurosurgery at Baylor St. Luke's Medical Center in Houston.